Literature DB >> 12642459

Homotropic versus heterotopic cooperativity of cytochrome P450eryF: a substrate oxidation and spectral titration study.

Kishore K Khan1, Hong Liu, James R Halpert.   

Abstract

P450eryF is the only bacterial P450 to show cooperativity of substrate binding and oxidation. However, the studies reported so far have provided evidence only for homotropic cooperativity of P450eryF but not for heterotropic cooperativity. Therefore, oxidation of 7-benzyloxyquinoline (7-BQ) and 1-pyrenebutanol (1-PB) by P450eryF A245T and spectral binding of 9-aminophenanthrene (9-AP) to wild-type P450eryF were investigated in the presence of various effectors. The addition of steroids and flavones caused no stimulation but rather moderate inhibition of 7-BQ or 1-PB oxidation by P450eryF A245T. However, the binding affinity of 9-AP was significantly increased in the presence of androstenedione or alpha-naphthoflavone (ANF). A comparative study with CYP3A4 revealed a similar increase in the binding affinity of 9-AP for the enzyme at low ANF concentrations but some competition at higher ANF concentrations. These studies, to our knowledge, provide the first report of heterotropic cooperativity in P450eryF as well as spectroscopic evidence for simultaneous presence of two ligand molecules in the CYP3A4 active site.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642459     DOI: 10.1124/dmd.31.4.356

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  Multiple ligand docking by Glide: implications for virtual second-site screening.

Authors:  Márton Vass; Ákos Tarcsay; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2012-05-26       Impact factor: 3.686

Review 2.  Substrate binding to cytochromes P450.

Authors:  Emre M Isin; F Peter Guengerich
Journal:  Anal Bioanal Chem       Date:  2008-07-13       Impact factor: 4.142

3.  Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4.

Authors:  Abhinav Nath; Cristina Fernández; Jed N Lampe; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2008-03-25       Impact factor: 4.013

4.  Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe.

Authors:  Tamara N Tsalkova; Nadezhda Y Davydova; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

5.  Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probe.

Authors:  Dmitri R Davydov; Alexandra E Botchkareva; Nadezhda E Davydova; James R Halpert
Journal:  Biophys J       Date:  2005-04-15       Impact factor: 4.033

6.  Resolution of multiple substrate binding sites in cytochrome P450 3A4: the stoichiometry of the enzyme-substrate complexes probed by FRET and Job's titration.

Authors:  Harshica Fernando; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2006-04-04       Impact factor: 3.162

7.  Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects.

Authors:  Agneta Wennerholm; Annika Allqvist; Jan-Olof Svensson; Lars L Gustafsson; Rajaa A Mirghani; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2005-04-02       Impact factor: 2.953

8.  Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.

Authors:  Yousong Ding; Wolfgang H Seufert; Zachary Q Beck; David H Sherman
Journal:  J Am Chem Soc       Date:  2008-03-26       Impact factor: 15.419

9.  Allosteric transitions in cytochrome P450eryF explored with pressure-perturbation spectroscopy, lifetime FRET, and a novel fluorescent substrate, Fluorol-7GA.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; James R Halpert
Journal:  Biochemistry       Date:  2008-10-02       Impact factor: 3.162

Review 10.  Cooperative properties of cytochromes P450.

Authors:  Ilia G Denisov; Daniel J Frank; Stephen G Sligar
Journal:  Pharmacol Ther       Date:  2009-06-23       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.